| CYSB2400063 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-03-08 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| CYSB2300010 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2023-01-11 | | Zhuhai United Laboratories Co Ltd | | | view |
| CYSB2300011 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2023-01-11 | | Zhuhai United Laboratories Co Ltd | | | view |
| CYSB2200124 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-05-31 | | Gan & Lee Pharmaceuticals | | | view |
| CXSS2200009 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2022-01-28 | | Jilin Huisheng Biopharmaceutical Co Ltd | | | view |
| CYSB2200004 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-01-06 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| JYSB2200003 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-01-06 | | Novo Nordisk A/S | | | view |
| CYSB2200005 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-01-06 | | Novo Nordisk (China) Pharmaceuticals Co Ltd | | | view |
| JYSB2200002 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-01-06 | | Novo Nordisk A/S | | | view |
| CXSS2101012 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.4) | New Drug Application | 2021-07-14 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
| CYSB2101049 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2021-04-23 | | Gan & Lee Pharmaceuticals | | | view |
| CXSS2100019 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(3.3) | New Drug Application | 2021-02-11 | 宜昌东阳光长江药业股份有限公司 | Yichang HEC Changjiang Pharmaceutical Co Ltd | In Review | 2021-02-10 | view |
| JYSB2000230 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2020-06-05 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-06-11 | view |
| JYSB2000231 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2020-06-05 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-06-11 | view |
| CXSL2000109 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2020-05-30 | 江苏万邦生化医药集团有限责任公司 | Wanbang Biopharmaceuticals | In Review | 2020-05-29 | view |
| CYSB2000101 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2020-05-22 | 诺和诺德（中国）制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | In Review | 2020-06-28 | view |
| JYSF1900009 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2019-08-24 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2019-09-19 | view |
| JTS1900036 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Disposable Import Drug Application | 2019-08-03 | Novo Nordisk A/S | Novo Nordisk A/S | Certificate Issued | 2019-08-29 | view |
| JYSZ1800051 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | License Renew | 2018-10-11 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2019-08-15 | view |
| JYSZ1800052 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | License Renew | 2018-10-11 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2019-08-15 | view |
